<DOC>
	<DOC>NCT02555267</DOC>
	<brief_summary>This study investigate the impact of comprehensive geriatric assessments using activity of daily living (ADL), instrumental activity of daily living (IADL), and Charlson's comorbidity index (CCI) on survival and toxicities in Korean patients with diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP.</brief_summary>
	<brief_title>Geriatric Assessments in Elderly Diffuse Large B-cell Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma, B-Cell</mesh_term>
	<mesh_term>Lymphoma, Large B-Cell, Diffuse</mesh_term>
	<criteria>Patients with newly diagnosed CD20+ DLBCL 65 years old or over Scheduled to receive RCHOP chemotherapy Informed consent Other histology than CD20+ DLBCL Primary central nervous system DLBCL Patients with a diagnosis of cancer (other than basal or squamous cell carcinoma of the skin, cervical carcinoma in situ, well differentiated thyroid cancer [papillary or follicular thyroid cancer]) within 3 years before the study entry or with any treatment for cancer within 3 years before entry Consent withdrawal</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>geriatric assessment</keyword>
	<keyword>diffuse large B-cell lymphoma</keyword>
	<keyword>activity of daily living</keyword>
	<keyword>instrumental activity of daily living</keyword>
	<keyword>Charlson's comorbidity index</keyword>
</DOC>